PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

Objective: To evaluate the efficacy of poly ADP ribose polymerase (PARP) inhibitors (PARPis) in breast and ovarian cancer with BRCA (BReast CAncer susceptibility gene) mutation (BRCAm). Methods: We conducted a meta-analysis of randomized controlled, phase II or III trials by searching of electronic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Aging (Albany NY)
Main Authors: Shao, Fengping, Duan, Yaoyun, Zhao, Yunhe, Li, Yinguang, Liu, Jun, Zhang, Cai, He, Shanyang
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals 2021
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034970/
https://ncbi.nlm.nih.gov/pubmed/33705352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202724
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados